中國人壽(02628.HK)選舉林志權為獨立董事
格隆匯 10 月 19日丨中國人壽(02628.HK)公告,中國人壽保險股份有限公司(以下簡稱“公司”)董事會於2020年10月19日收到獨立董事張祖同的辭任函。因連任獨立董事時間滿六年,根據相關監管規定,張祖同向董事會提出辭任公司獨立董事、戰略與資產負債管理委員會主席、審計委員會委員及關聯交易控制委員會委員職務。
公司於2020年6月29日召開的2019年年度股東大會已選舉林志權為第六屆董事會獨立董事以接替張祖同,目前林志權的任職資格尚待中國銀行保險監督管理委員會(“中國銀保監會”)核准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.